Review of Gaucher's Disease, Conventional Medical Regimen, and Herbal Adjuvants: Relevance and Utility in the Indian Milieu

Abstract

Gaucher disease (GD) is a rare, inherited lysosomal storage disorder characterized by the accumulation of fatty substances due to an enzyme deficiency. Conventional medical management, primarily through Enzyme Replacement Therapy (ERT) and Substrate Reduction Therapy (SRT), has significantly transformed the prognosis for non-neuronopathic forms of the disease globally. However, the practical application and effectiveness of these therapies in India are profoundly influenced by a unique set of challenges. These include the exorbitant cost of imported medications, significant diagnostic delays, and an underdeveloped healthcare infrastructure for rare diseases. The genetic landscape in India presents a higher prevalence of neuronopathic Type 3 Gaucher disease, for which conventional therapies offer limited benefit due to their inability to cross the blood-brain barrier. This creates a substantial unmet medical need within the Indian patient population. While traditional Indian medicine systems, such as Ayurveda and Homoeopathy, are widely practiced and may offer symptomatic relief, robust scientific evidence supporting their disease-modifying capabilities for Gaucher disease is currently lacking. Furthermore, potential drug interactions, particularly with SRTs, necessitate extreme caution when combining therapies. Addressing the challenges in India requires a multi-pronged approach. Strategic initiatives focusing on indigenous manufacturing of affordable therapies, strengthening diagnostic pathways through increased awareness and specialized centres, and fostering public-private partnerships are crucial. The government's National Policy for Rare Diseases (NPRD) 2021 represents a foundational step, but its successful implementation hinges on sustained fiscal allocation, improved logistical frameworks, and a continued focus on making life-saving treatments accessible and affordable for all affected individuals.